Jan.21,2025 MUHC Medical Grand Rounds by Dr Kaberi Dasgupta MD, CM, MSc (Epidemiology)

Описание: Title: Exercise as Medicine: Prescribing and Packaging for Diabetes Treatment, Remission, and Prevention
Speaker: Dr Kaberi Dasgupta MD, CM, MSc (Epidemiology), Professor of Medicine and McGill Director of the Division of General Internal Medicine (GIM)- McGill University Physician- McGill University Health Centre (MUHC) Senior Scientist- Centre for Outcomes Research and Evaluation (CORE), RI-MUHC

MUHC Hybrid Medical Grand Rounds Tuesday, 1/21/2025 at 12h00-13h00
*Please note technical issues caused late start for recording that would have included McGill University Land Acknowledgment from Dr. Giannetti and some of Dr. Suzanne Morin's Introduction of speaker**

Educational objectives
1) To understand step metrics, links with clinical outcomes, impact of step count prescription in type 2 diabetes and hypertension, promise of step count tracking with weekly targets in gestational diabetes
2) To appreciate potential impacts of supervised exercise and potential synergies with low calorie diets to achieve type 2 diabetes remission
3) To consider the persistent importance of exercise as medicine in an incretin era of GIP and GLP agonists

Biosketch of Dr Kaberi Dasgupta MD, CM, MSc (Epidemiology):
Kaberi Dasgupta is a Physician, Scientist, and Professor of Medicine at McGill University and the McGill University Health Centre, and McGill Director of General Internal Medicine. Her research focus is prevention, remission, and self-management support in diabetes. Her research is funded by the CIHR, Heart & Stroke Foundation, Lawson Foundation, and Diabetes Canada. She has published over 160 papers and her research has received a high level of media coverage because of its direct relevance to patients, practitioners, and policy makers. She is co-author of Diabetes Canada clinical practice guidelines on remission, physical activity, and type 2 diabetes pharmacotherapy.

Version Français: Kaberi Dasgupta est médecin, scientifique et professeure de médecine à l'Université McGill et au Centre Universitaire de Santé McGill et directrice de la médecine interne générale de McGill. Ses recherches portent sur la prévention, la rémission et le soutien à l'autogestion du diabète. Ses projets de recherche sont financés par l'IRSC, la Fondation des maladies du coeur et de l'AVC du Canada, la Fondation Lawson et Diabète Canada. Elle a publié plus de 160 articles et ses recherches ont reçu une grande couverture médiatique en raison de leur pertinence directe pour les patients, le personnel de santé et les législateurs. Elle est co-auteure des lignes directrices des pratiques cliniques de Diabète Canada sur la rémission, l'activité physique et la pharmacothérapie du diabète de type 2.